These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19438477)

  • 1. The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis.
    Cheng T; Tjabringa GS; van Vlijmen-Willems IM; Hitomi K; van Erp PE; Schalkwijk J; Zeeuwen PL
    Br J Dermatol; 2009 Aug; 161(2):253-64. PubMed ID: 19438477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of cystatin M/E and its cognate target proteases.
    Zeeuwen PL; Cheng T; Schalkwijk J
    J Invest Dermatol; 2009 Jun; 129(6):1327-38. PubMed ID: 19262604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colocalization of cystatin M/E and its target proteases suggests a role in terminal differentiation of human hair follicle and nail.
    Cheng T; van Vlijmen-Willems IM; Hitomi K; Pasch MC; van Erp PE; Schalkwijk J; Zeeuwen PL
    J Invest Dermatol; 2009 May; 129(5):1232-42. PubMed ID: 19005484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin B as a potential cystatin M/E target in the mouse hair follicle.
    Oortveld MAW; van Vlijmen-Willems IMJJ; Kersten FFJ; Cheng T; Verdoes M; van Erp PEJ; Verbeek S; Reinheckel T; Hendriks WJAJ; Schalkwijk J; Zeeuwen PLJM
    FASEB J; 2017 Oct; 31(10):4286-4294. PubMed ID: 28596234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cystatin M/E-cathepsin L balance is essential for tissue homeostasis in epidermis, hair follicles, and cornea.
    Zeeuwen PL; van Vlijmen-Willems IM; Cheng T; Rodijk-Olthuis D; Hitomi K; Hara-Nishimura I; John S; Smyth N; Reinheckel T; Hendriks WJ; Schalkwijk J
    FASEB J; 2010 Oct; 24(10):3744-55. PubMed ID: 20495178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin M / E expression in inflammatory and neoplastic skin disorders.
    Zeeuwen PL; van Vlijmen-Willems IM; Egami H; Schalkwijk J
    Br J Dermatol; 2002 Jul; 147(1):87-94. PubMed ID: 12100189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase.
    Zeeuwen PL; Van Vlijmen-Willems IM; Jansen BJ; Sotiropoulou G; Curfs JH; Meis JF; Janssen JJ; Van Ruissen F; Schalkwijk J
    J Invest Dermatol; 2001 May; 116(5):693-701. PubMed ID: 11348457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice.
    Zeeuwen PL; van Vlijmen-Willems IM; Olthuis D; Johansen HT; Hitomi K; Hara-Nishimura I; Powers JC; James KE; op den Camp HJ; Lemmens R; Schalkwijk J
    Hum Mol Genet; 2004 May; 13(10):1069-79. PubMed ID: 15044380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colocalization of cystatin M/E and cathepsin V in lamellar granules and corneodesmosomes suggests a functional role in epidermal differentiation.
    Zeeuwen PL; Ishida-Yamamoto A; van Vlijmen-Willems IM; Cheng T; Bergers M; Iizuka H; Schalkwijk J
    J Invest Dermatol; 2007 Jan; 127(1):120-8. PubMed ID: 16874311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
    Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
    J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of a human endogenous retrovirus E transmembrane envelope glycoprotein in normal, psoriatic and atopic dermatitis human skin.
    Bessis D; Molès JP; Basset-Séguin N; Tesniere A; Arpin C; Guilhou JJ
    Br J Dermatol; 2004 Oct; 151(4):737-45. PubMed ID: 15491412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis.
    Kamsteeg M; Jansen PA; van Vlijmen-Willems IM; van Erp PE; Rodijk-Olthuis D; van der Valk PG; Feuth T; Zeeuwen PL; Schalkwijk J
    Br J Dermatol; 2010 Mar; 162(3):568-78. PubMed ID: 19818069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair.
    de Koning HD; van den Bogaard EH; Bergboer JG; Kamsteeg M; van Vlijmen-Willems IM; Hitomi K; Henry J; Simon M; Takashita N; Ishida-Yamamoto A; Schalkwijk J; Zeeuwen PL
    Br J Dermatol; 2012 Jun; 166(6):1245-54. PubMed ID: 22329734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis.
    de Jongh GJ; Zeeuwen PL; Kucharekova M; Pfundt R; van der Valk PG; Blokx W; Dogan A; Hiemstra PS; van de Kerkhof PC; Schalkwijk J
    J Invest Dermatol; 2005 Dec; 125(6):1163-73. PubMed ID: 16354186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression pattern of somatostatin receptor subtypes 1-5 in human skin: an immunohistochemical study of healthy subjects and patients with psoriasis or atopic dermatitis.
    Hagströmer L; Emtestam L; Stridsberg M; Talme T
    Exp Dermatol; 2006 Dec; 15(12):950-7. PubMed ID: 17083361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal expression of host response genes upon skin barrier disruption in normal skin and uninvolved skin of psoriasis and atopic dermatitis patients.
    de Koning HD; Kamsteeg M; Rodijk-Olthuis D; van Vlijmen-Willems IM; van Erp PE; Schalkwijk J; Zeeuwen PL
    J Invest Dermatol; 2011 Jan; 131(1):263-6. PubMed ID: 20861857
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidermal differentiation: the role of proteases and their inhibitors.
    Zeeuwen PL
    Eur J Cell Biol; 2004 Dec; 83(11-12):761-73. PubMed ID: 15679120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant protein D in atopic dermatitis and psoriasis.
    Hohwy T; Otkjaer K; Madsen J; Søerensen G; Nielsen O; Vestergaard C; Steiniche T; Holmskov U; Lomholt H
    Exp Dermatol; 2006 Mar; 15(3):168-74. PubMed ID: 16480424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin-like skin protein level increases in the differentiated epidermal layers in atopic dermatitis.
    Donovan M; Ambach A; Thomas-Collignon A; Prado C; Bernard D; Jammayrac O; Gollnick H; de Lacharriere O
    Exp Dermatol; 2013 Dec; 22(12):836-7. PubMed ID: 24279918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis.
    Devos M; Mogilenko DA; Fleury S; Gilbert B; Becquart C; Quemener S; Dehondt H; Tougaard P; Staels B; Bachert C; Vandenabeele P; Van Loo G; Staumont-Salle D; Declercq W; Dombrowicz D
    J Invest Dermatol; 2019 Jan; 139(1):135-145. PubMed ID: 30118730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.